Innovus Pharmaceuticals Supplement Androferti Improves Male Fertility, says top medical expert
When people have trouble conceiving, low sperm count or poor quality sperm is to blame in about 40% of the cases, but better diets and lifestyles, and a supplement from Innovus Pharmaceuticals called Androferti(R), can make a major difference
(firmenpresse) - SAN DIEGO, CA -- (Marketwired) -- 10/20/16 -- The ("VCRM"), one of the nation's leading fertility centers, today recommends ®, a supplement from San Diego-based , Inc. (OTCQB: INNV), an emerging commercial-stage pharmaceutical company.
The supplement can be used to help solve the growing issue of male infertility, says , founder and Medical Director of the (VCRM).
When couples have trouble conceiving, the conventional wisdom is that the problem lies with the woman. "But that's true in only about 40% of cases," explains Dr. Sharara. "In another 40% of cases, the problem is male fertility -- low sperm counts and poor quality sperm."
There are also suggesting that sperm counts and quality are declining in the U.S. and around the world, because of diet, , sedentary lifestyles, and other aspects of modern life. "When people do not eat well, or when they are overweight or smoke or take drugs, the sperm suffers," explains Dr. Sharara.
The good news, however, is that male fertility is a treatable problem. The steps to take, Dr. Sharara says, include taking Androferti. Here are his full recommendations:
Stop smoking
Cut back on drinking (and ideally, stopping entirely)
Don't put laptop computers on laps, since that raises the temperature of the testes and damages sperm
When exercising, don't wear tight compression shorts
Take Androferti, which is designed to improve sperm count and quality
"We have tried a number of supplements that claim to improve sperm," explains Dr. Sharara. "Most include an amino acid called that has been shown to increase sperm count and movement."
But the supplements don't all work equally well. The best by far, in VCRM's experience, is Androferti®, which contains a patented formulation containing vitamin C, coenzyme Q10, and vitamin B12, in addition to L-carnitine. "We switched to Androferti® about six months ago, and the improvement we are seeing has been impressive," says Dr. Sharara. "We are seeing more than 50% improvements in sperm count, morphology, and motility. That's also similar to what has been ."
"This is one of the best, if not the best, products on the market," says Dr. Sharara. "I believe it could help couples conceive the children that they so desperately want."
Headquartered in San Diego, Innovus Pharma is an emerging commercial stage pharmaceutical company delivering over-the-counter medicines and consumer care products for men's and women's health and respiratory diseases. The Company generates revenues from its lead products (a) BTH® Testosterone Booster, (b) BTH® Human Growth Agent, (c) Zestra® for female arousal and (d) EjectDelay® for premature ejaculation and has an additional five marketed products in this space, including (e) Sensum+® to help with reduced penile sensitivity, (f) Zestra Glide®, (g) Vesele® for promoting sexual health, (h) RecalMax™ for promoting brain and cognitive health, (i) Androferti® (in the US and Canada) to support overall male reproductive health and sperm quality, (j) BTH Vision Formula, (k) BTH Blood Sugar, among others and eventually FlutiCare™ OTC for allergic rhinitis, if its ANDA is approved by the U.S. FDA.
For more information, go to , ; ; ; ; ; ; ; ; ; .
Statements under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including, but not limited to, results from the above pre-clinical and clinical trial, projected revenues, projected online subscribers, estimated market for its products, and statements about achieving its other development, growth, commercialization, financial and staffing objectives. Readers are cautioned not to place undue reliance on these forward-looking statements as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's most recent annual report on Form 10-K, subsequent quarterly reports filed on Form 10-Q and other filings made with the SEC. Copies of these reports are available from the SEC's website or without charge from the Company.
Image Available:
Contact:
Dr. Bassam Damaj
CEO
Innovus Pharmaceuticals, Inc. (OTCQB Venture Market: INNV)
PHONE IS 858-663-1159
EMAIL IS :
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.10.2016 - 13:30 Uhr
Sprache: Deutsch
News-ID 501826
Anzahl Zeichen: 0
contact information:
Town:
SAN DIEGO, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 472 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Innovus Pharmaceuticals Supplement Androferti Improves Male Fertility, says top medical expert"
steht unter der journalistisch-redaktionellen Verantwortung von
Innovus Pharmaceuticals, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
